Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F MARKER

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Neuro-Oncology Advances|May 4, 2026
Clinical characteristics and outcomes of adult IDH-mutant brainstem gliomas: Institutional case series and systematic reviewMaged T Ghoche, Kenji Miki, Fanen Yuan, et al.
Journal of Medicinal Chemistry|September 19, 2013
Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3Val S Goodfellow, Colin J Loweth, Satheesh B Ravula, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2013
The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disordersDaniel F Marker, Marie-Ève Tremblay, Jenna M Puccini, et al.
Neuro-Oncology|June 8, 2026
Genomic hallmarks of depot medroxyprogesterone acetate-associated meningiomasSakibul Huq, Taylor A Gatesman, Hussam Abou-Al-Shaar, et al.
The Lancet. Oncology|February 5, 2026
Classification accuracy of a hierarchical molecular inference-based deep-learning system for CNS tumour diagnosis: a multi-institutional, retrospective studyH Lalchungnunga, Christopher H Dampier, Omkar Singh, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Neuro-Oncology Advances|May 4, 2026
Clinical characteristics and outcomes of adult IDH-mutant brainstem gliomas: Institutional case series and systematic reviewMaged T Ghoche, Kenji Miki, Fanen Yuan, et al.
Journal of Medicinal Chemistry|September 19, 2013
Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3Val S Goodfellow, Colin J Loweth, Satheesh B Ravula, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2013
The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disordersDaniel F Marker, Marie-Ève Tremblay, Jenna M Puccini, et al.
Neuro-Oncology|June 8, 2026
Genomic hallmarks of depot medroxyprogesterone acetate-associated meningiomasSakibul Huq, Taylor A Gatesman, Hussam Abou-Al-Shaar, et al.
The Lancet. Oncology|February 5, 2026
Classification accuracy of a hierarchical molecular inference-based deep-learning system for CNS tumour diagnosis: a multi-institutional, retrospective studyH Lalchungnunga, Christopher H Dampier, Omkar Singh, et al.
Pageof 3